Agios Pharmaceuticals, Inc. (AGIO) vs Generate Biomedicines, Inc. (GENB)
A side-by-side comparison of Agios Pharmaceuticals, Inc. and Generate Biomedicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGIO
Agios Pharmaceuticals, Inc.
$31.71HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
GENB
Generate Biomedicines, Inc.
$13.93HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — AGIO vs GENB
growth of $100 · dividends reinvested · last 1yAGIO +3.4% (+3.4%/yr)GENB +10.0% (+10.0%/yr)GENB compounded faster over this window
AGIO GENB
AGIO vs GENB: by the numbers
- •AGIO is the larger company ($1.89B vs $1.79B market cap).
- •Both run net losses; AGIO's is the smaller (-418.24% vs -636.99% net margin).
Metrics side by side
Valuation
| Metric | AGIO | GENB |
|---|---|---|
| P/S ratio | 19.25 | N/A |
| P/B ratio | 1.84 | 3.92 |
Profitability
| Metric | AGIO | GENB |
|---|---|---|
| Gross margin | 78.67% | 100.00% |
| Operating margin | -873.87% | -737.04% |
| Net margin | -418.24% | -636.99% |
| ROE | -40.09% | N/A |
| ROIC | -44.21% | -94.79% |
Growth (annualized)
| Metric | AGIO | GENB |
|---|---|---|
| Revenue CAGR (5Y) | 4.54% | N/A |
| Total return CAGR (5Y) | -6.59% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.